These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7542463)

  • 1. The charybdotoxin family of K+ channel-blocking peptides.
    Miller C
    Neuron; 1995 Jul; 15(1):5-10. PubMed ID: 7542463
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural determinants of scorpion toxin affinity: the charybdotoxin (alpha-KTX) family of K(+)-channel blocking peptides.
    Tenenholz TC; Klenk KC; Matteson DR; Blaustein MP; Weber DJ
    Rev Physiol Biochem Pharmacol; 2000; 140():135-85. PubMed ID: 10857399
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the blocking activity of charybdotoxin homologs and iodinated derivatives against Ca2+-activated K+ channels.
    Lucchesi K; Ravindran A; Young H; Moczydlowski E
    J Membr Biol; 1989 Aug; 109(3):269-81. PubMed ID: 2477548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
    Gao YD; Garcia ML
    Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of iberiotoxin, a potent blocker of the large conductance Ca(2+)-activated K+ channel.
    Candia S; Garcia ML; Latorre R
    Biophys J; 1992 Aug; 63(2):583-90. PubMed ID: 1384740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scorpion toxins for the reversal of BoNT-induced paralysis.
    Lowery CA; Adler M; Borrell A; Janda KD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6743-6. PubMed ID: 24252544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scorpion toxins as tools for studying potassium channels.
    Garcia ML; Hanner M; Knaus HG; Slaughter R; Kaczorowski GJ
    Methods Enzymol; 1999; 294():624-39. PubMed ID: 9916251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional features of noxiustoxin: a K+ channel blocker.
    Gurrola GB; Possani LD
    Biochem Mol Biol Int; 1995 Oct; 37(3):527-35. PubMed ID: 8595393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor.
    MacKinnon R; Heginbotham L; Abramson T
    Neuron; 1990 Dec; 5(6):767-71. PubMed ID: 1702643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular effects of some potassium channel blocking toxins from the venom of the scorpion Leiurus quinquestriatus hebreus.
    Marshall DL; Vatanpour H; Harvey AL; Boyot P; Pinkasfeld S; Doljansky Y; Bouet F; Ménez A
    Toxicon; 1994 Nov; 32(11):1433-43. PubMed ID: 7533951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block of maurotoxin and charybdotoxin on human intermediate-conductance calcium-activated potassium channels (hIKCa1).
    Visan V; Sabatier JM; Grissmer S
    Toxicon; 2004 Jun; 43(8):973-80. PubMed ID: 15208030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Martentoxin, a novel K+-channel-blocking peptide: purification, cDNA and genomic cloning, and electrophysiological and pharmacological characterization.
    Ji YH; Wang WX; Ye JG; He LL; Li YJ; Yan YP; Zhou Z
    J Neurochem; 2003 Jan; 84(2):325-35. PubMed ID: 12558995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary structure of noxiustoxin and charybdotoxin from hydropathy power spectra.
    Sacile R; Ruggiero C; Ballestrero R; Possani LD; Prestipino G; Rauch G
    Biochem Biophys Res Commun; 1994 May; 201(1):186-93. PubMed ID: 7515231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and sequencing of two 'short chain' and two 'long chain' K(+) channel-blocking peptides from the Chinese scorpion Buthus martensii Karsch.
    Zhu S; Li W; Zeng X; Jiang D; Mao X; Liu H
    FEBS Lett; 1999 Sep; 457(3):509-14. PubMed ID: 10471839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of charybdotoxin block of a voltage-gated K+ channel.
    Goldstein SA; Miller C
    Biophys J; 1993 Oct; 65(4):1613-9. PubMed ID: 7506068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel K+ channel blocking toxin from Tityus discrepans scorpion venom.
    D'Suze G; Zamudio F; Gómez-Lagunas F; Possani LD
    FEBS Lett; 1999 Jul; 456(1):146-8. PubMed ID: 10452547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A charybdotoxin-sensitive, Ca(2+)-activated K+ channel with inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins.
    Van Renterghem C; Vigne P; Frelin C
    J Neurochem; 1995 Sep; 65(3):1274-81. PubMed ID: 7543933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charybdotoxin, dendrotoxin and mast cell degranulating peptide block the voltage-activated K+ current of fibroblast cells stably transfected with NGK1 (Kv1.2) K+ channel complementary DNA.
    Werkman TR; Kawamura T; Yokoyama S; Higashida H; Rogawski MA
    Neuroscience; 1992 Oct; 50(4):935-46. PubMed ID: 1280351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes.
    Garcia-Valdes J; Zamudio FZ; Toro L; Possani LD
    FEBS Lett; 2001 Sep; 505(3):369-73. PubMed ID: 11576530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currents.
    Huys I; Xu CQ; Wang CZ; Vacher H; Martin-Eauclaire MF; Chi CW; Tytgat J
    Biochem J; 2004 Mar; 378(Pt 3):745-52. PubMed ID: 14599291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.